1. Single center, open label dose escalating trial evaluating once weekly oral ixazomib in ART-suppressed, HIV positive adults and effects on HIV reservoir size in vivo. (December 2021) Authors: Cummins, Nathan W; Baker, Jason; Chakraborty, Rana; Dean, Patrick G; Garcia-Rivera, Enrique; Krogman, Ashton; Kumar, Shaji; Kuzmichev, Yury V; Laird, Gregory M; Landay, Alan; Lichterfeld, Mathias; Mahmood, Maryam; Martinson, Jeffrey; Maynes, Mark; Natesampillai, Sekar; Rajkumar, Vincent; Rassadki... Journal: EClinicalMedicine Issue: Volume 42(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Single center, open label dose escalating trial evaluating once weekly oral ixazomib in ART-suppressed, HIV positive adults and effects on HIV reservoir size in vivo. (December 2021) Authors: Cummins, Nathan W; Baker, Jason; Chakraborty, Rana; Dean, Patrick G; Garcia-Rivera, Enrique; Krogman, Ashton; Kumar, Shaji; Kuzmichev, Yury V; Laird, Gregory M; Landay, Alan; Lichterfeld, Mathias; Mahmood, Maryam; Martinson, Jeffrey; Maynes, Mark; Natesampillai, Sekar; Rajkumar, Vincent; Rassadki... Journal: EClinicalMedicine Issue: Volume 42(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗